Quarterly report [Sections 13 or 15(d)]

Commitments and Contingencies (Details Narrative)

v3.25.2
Commitments and Contingencies (Details Narrative) - USD ($)
$ in Thousands
1 Months Ended 6 Months Ended
Aug. 31, 2024
Sep. 30, 2023
Apr. 30, 2023
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Aug. 03, 2022
Defined Benefit Plan Disclosure [Line Items]              
Operating lease, weighted average discount rate       6.40%      
Operating lease, weighted average remaining lease term       4 years 9 months 18 days      
Current operating lease liability       $ 317   $ 301  
Payment lease cost $ 163 $ 571 $ 1,224        
Debt discount rate 10.75% 6.00% 6.00%        
Operating lease expense       205 $ 189    
Phase 2a Clinical Trial [Member]              
Defined Benefit Plan Disclosure [Line Items]              
Prepaid reservation fee             $ 1,700
Estimated agreement cost       6,900      
Related Party [Member]              
Defined Benefit Plan Disclosure [Line Items]              
Current operating lease liability       52   $ 49  
Operating lease expense       $ 32 $ 31